Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

EQS-News: Cantourage Group SE: NuWays confirms 'Buy' recommendation

eqs_en 
0 0 25.10.23
EQS-News: Cantourage Group SE: NuWays confirms 'Buy' recommendation
 

EQS-News: Cantourage Group SE / Key word(s): Research Update
Cantourage Group SE: NuWays confirms 'Buy' recommendation

25.10.2023 / 11:32 CET/CEST
The issuer is solely responsible for the content of this announcement.

Not for publication or distribution, directly or indirectly, in or into the United States of America, Australia, Canada or Japan or any other jurisdiction in which such publication or distribution would be unlawful. The important notices at the end of this press release should be observed.

Cantourage Group SE: NuWays confirms "Buy" recommendation
 

Berlin, October 25, 2023 – In a research update published today, the research house NuWays AG, Hamburg, once again rates the shares of Cantourage Group SE (hereinafter "Cantourage", ISIN: DE000A3DSV01, www.cantourage.com/en) with a "Buy" recommendation and a price target of EUR 12.50. Further information is available at https://www.cantourage.com/en/investors/analysts.
 

About Cantourage
Cantourage is a leading European producer and distributor of cannabis-based medicinal preparations and drugs. The Berlin-based company was founded in 2019 by industry pioneers Norman Ruchholtz, Dr. Florian Holzapfel and Patrick Hoffmann. With an experienced management team and its “Fast Track Access” platform, Cantourage enables producers from around the world to become part of the growing European medical cannabis market faster, easier and more cost-effectively by processing and distributing their cannabis raw materials and extracts. In this context, Cantourage ensures compliance with the highest European pharmaceutical quality standards at all times. The company offers pharmaceutical-grade products in all relevant market segments: dried flower, extracts, dronabinol and cannabidiol. Cantourage was listed on the Frankfurt Stock Exchange on November 11, 2022 and is listed under ticker symbol “HIGH”.

For further information: www.cantourage.com/en
 

This announcement does not constitute a public offer or an advertisement for a public offer for sale of securities, in particular within the meaning of Regulation (EU) 2017/1129 (Prospectus Regulation).

 

Press contact at Cantourage:
Stefanie Frey
Tel. +49 (0)30 4701 350 - 50
[email protected]


25.10.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
Language: English
Company: Cantourage Group SE
Feurigstraße 54
10827 Berlin
Germany
E-mail: [email protected]
Internet: https://www.cantourage.com/
ISIN: DE000A3DSV01
WKN: A3DSV0
Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Scale), Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1757201

 
End of News EQS News Service

1757201  25.10.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1757201&application_name=news&site_id=sharewise

Cantourage Group SE Stock

€5.10
-2.830%
We can see a decrease in the price for Cantourage Group SE. Compared to yesterday it has lost -€0.140 (-2.830%).
With 1 Sell predictions and 1 Buy predictions the community sentiment towards the Cantourage Group SE stock is not clear.
As a result the target price of 10 € shows a very positive potential of 96.08% compared to the current price of 5.1 € for Cantourage Group SE.
Show more
Like: 0
Share
eqs_en 
EQS Group is a leading international provider of regulatory technology in the fields of corporate compliance and investor relations. In working with EQS Group, thousands of companies worldwide inspire trust by fulfilling complex national and international disclosure obligations, minimizing risks and communicating transparently with stakeholders.




Legal notice

Comments

Not a member yet? Sign up for free!